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Background: Squamous papillomas are exophytic proliferations of surface oral epithelium.  Human papillomavirus 
(HPV) infection is widely accepted as the etiology of squamous papillomas however the virus cannot be detected 
in a significant percentage of lesions. 
Material and Methods: Using polymerase chain reaction (PCR), we tested 35 formalin-fixed paraffin-embedded 
(FFPE) squamous papillomas for the presence of HPV DNA.  
Results: Six papillomas (17%) tested positive for HPV DNA; four contained HPV-6 and two contained HPV-11. 
Given that β–globin DNA was only identified in half of the samples, DNA degradation appears to have significantly 
impacted the results.  
Conclusions: The results likely represent an underestimation of the true number of HPV-positive specimens in our 
study.  Potential explanations for HPV-negative squamous papillomas include transient HPV infection, failure of 
the experiment to detect HPV if present, or the possibility that some lesions may not result from HPV infection.




Squamous papilloma represents the most common be-
nign epithelial neoplasm of the oral cavity (1). The cli-
nical presentation is a solitary, asymptomatic, exophytic 
lesion with either finger-like or cauliflower-like surface 
projections (Figs. 1,2). The color varies from pink to 
white depending on the amount of keratin produced. 
Squamous papillomas can occur at any age and in any 
oral location. The palate, tongue, and lips are most often 
affected (2).  
The etiology of squamous papilloma has been attributed 
to infection with low-risk human papillomavirus (HPV) 
genotypes such as 6 and 11.  HPV DNA is detected in an 
average of 34% of oral squamous papillomas however a 
wide range of detection rates have been reported using 
various experimental methods (3). HPV testing is not 
Article Number: 55187               http://www.medicinaoral.com/odo/indice.htm







Daigrepont J, Cameron JE, Wright KL, Cordell KG, Rosebush MS. Detection 
of human papillomavirus DNA in formalin-fixed, paraffin-embedded squa-
mous papillomas of the oral cavity. J Clin Exp Dent. 2018;10(10):e979-83.
http://www.medicinaoral.com/odo/volumenes/v10i10/jcedv10i10p979.pdf
J Clin Exp Dent. 2018;10(10):e979-83.                                                                                                                                                                          HPV in oral squamous papillomas
e980
routinely performed on papillomas, therefore the precise 
contribution of HPV to the development of squamous 
papillomas is not fully understood. The possibility that 
some papillomas could have a non-viral cause is sug-
gested by the inability to detect HPV DNA in a large 
proportion of lesions.  In contrast, nearly all cases of oral 
condyloma acuminatum contain identifiable HPV (1,4) 
(5) and 86% of multifocal epithelial hyperplasia samples 
are HPV-positive (6).    
Archived formalin-fixed paraffin-embedded (FFPE) tis-
sue specimens represent a vast source of materials for 
use in research studies. FFPE tissues are the most com-
mon specimen stored in pathology laboratories. Analy-
sis of these specimens can allow us to determine the pre-
valence of HPV genotypes in multiple clinical lesions. 
There is no gold standard or FDA-approved method for 
HPV detection in FFPE tissues (7). In situ hybridization 
(ISH) is labor intensive and lacks sensitivity, therefore 
polymerase chain reaction (PCR) has been the preferred 
method in recent studies (7,8). Large panels of HPV ge-
notypes can be identified through the use of commercia-
lly-developed assays. In this study we sought to detect 
HPV DNA by PCR within FFPE oral squamous papillo-
mas to determine prevalence of infection and specific 
viral genotypes.   
Material and Methods
Thirty-five FFPE squamous papillomas submitted to the 
LSU Oral Pathology Biopsy Service archives between 
2014 and 2015 were selected. All specimens were re-
viewed microscopically by two oral pathologists (MR 
and KC) to confirm each was an ideal histopathologic 
representation of a squamous papilloma without signifi-
cant overlapping features with condyloma acuminatum, 
verruca vulgaris, or multifocal epithelial hyperplasia. 
Six specimens diagnosed as fibroma were selected to 
serve as negative controls, and a previously confirmed 
HPV DNA-positive cervical biopsy specimen was used 
as a positive control. This study was approved by the 
Louisiana State University Health Sciences Center Insti-
tutional Review Board (IRB# 3974).  
Using a microtome, five 10μm-thick sections were ob-
tained from each specimen. Genomic DNA was extrac-
ted using the QIAmp FFPE Tissue Kit following the ma-
nufacturer’s instructions (Qiagen). The DNA extraction 
was performed immediately following tissue sectioning. 
Quantity of DNA was determined by spectrophotometry 
(NanoDrop). Quality of DNA was determined by poly-
merase chain reaction (PCR) for the human β-globin 
gene. If a sample contained detectable β-globin DNA, 
then it was assumed that HPV DNA should be intact 
and amplified during PCR. PCR was performed on the 
extracted specimen DNA using three separate HPV-spe-
cific primer sets: MY09/11, FAP59/64, and SPF1/2 ac-
cording to published methods (9,10).  The PCR products 
were visualized by agarose gel electrophoresis.  For HPV 
DNA-positive specimens, genotype was determined by 
Roche Linear Array which detects the following 37 HPV 
genotypes:  6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 
51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 
70, 71, 72, 73 (MM9), 81, 82 (MM4), 83 (MM7), 84 
(MM8), IS39 and CP6108. Specimens testing positive 
for HPV were compared to specimens testing negative 
using a student’s t-test. A p-value of 0.05 was considered 
statistically significant.
Results
The squamous papilloma specimens came from 20 ma-
les and 15 females (1.33 M:F). The average patient age 
was 52 years old (range 10-85). The papillomas were 
harvested from a variety of intraoral areas; soft palate 
and tongue were the two most frequent locations (Table 
1). The HPV DNA extraction results are summarized in 
Table 2. Of the 35 squamous papillomas, 6 (17%) tes-
ted positive for HPV DNA; four specimens contained 
Fig. 1: Clinical presentation of a squamous papilloma on the ventral 
tongue.
Fig. 2: Histopathology of a squamous papilloma, low power.
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Table 2: HPV DNA extraction results for 35 squa-
mous papillomas.
HPV-6 DNA and the other two contained HPV-11 DNA. 
Among the six specimens that tested positive for HPV 
DNA, there was 83.3% concordance across the three 
PCR assays, with one specimen testing positive by the 
FAP59/64 and SP1/2 PCR assays but negative on the 
MY09/11 PCR assay. 
The presence of β-globin DNA was detected in 17 of 35 
papillomas (49%). Of the six HPV-positive samples, two 
(33%) were positive for β-globin.  Two of the 6 fibromas 
were positive for β-globin and no fibromas were positive 
for HPV. When comparing HPV-positive and HPV-ne-
gative squamous papillomas in our sample, there were 
no statistically significant differences in DNA quality 
(p=.1167), DNA quantity (p=.095), or formalin fixation 
time (p=.736) (Table 3). 
Discussion
In this report, we detected HPV 6 or 11 in 6 out of 35 
FFPE tissues diagnosed as oral squamous papillomas 
using a combination of HPV-specific PCR assays. Pre-
vious studies have identified HPV 6 and/or 11 in 13-35% 
of squamous papillomas by ISH (1,4,11) and in 48-68% 
HPV-positive HPV-negative p-values
DNA quality (260/280nm ratios) 2.72 2.21 0.1167
DNA Quantity (µg/µL) 52.2 50.6 0.095
Mean formalin fixation time (hours) 124 114 0.736
Table 3: DNA quality, DNA quantity, and formalin fixation time for HPV-positive versus HPV-
negative papillomas.
of papillomas by PCR (5,12,13). The lower detection 
rates observed with ISH is likely due to inadequate sen-
sitivity.  PCR is a very sensitive technique and therefore 
higher rates of HPV detection have been seen in studies 
which utilized this method.  A possible explanation for 
such a large variation in detection rate could be inclusion 
of cases of condyloma acuminatum in some studies (5). 
Additionally, small modifications to the experimental 
protocol can greatly influence amplification rates (14).    
We detected HPV DNA in only 17% of the papillomas 
in our study which is much lower than prior studies 
using PCR. A possible explanation for this outcome is 
suboptimal DNA extraction from fixation. Fixation of 
pathology specimens and embedding in paraffin wax are 
essential steps in processing tissues for microscopic eva-
luation and long-term preservation. The most popular 
fixative, 10% neutral buffered formalin, stabilizes cells 
by the formation of protein crosslinks.  Neutral buffered 
formalin has been identified as an acceptable fixative for 
the detection of HPV DNA by both ISH and PCR (8). 
In an experiment on cases of cervical cancer, Odida et 
al. found no statistically significant difference in HPV 
detection between freshly frozen samples and paraffin 
embedded tissue (15). HPV can reportedly be detected 
in FFPE samples for as many as 70 years post-fixation 
provided the target molecules are preserved (8). Unfor-
tunately, over-fixation can cause excessive formation of 
protein crosslinks, reducing the effectiveness of DNA 
detection by PCR due to physical fragmentation of nu-
cleic acids (8). Amplification of human cellular genes 
such as the β-globin gene is often used to determine the 
adequacy of extracted DNA for PCR amplification. If 
β–globin amplification is successful then HPV should be 
detected in that sample if present. β–globin DNA was 
only identified in 49%  of our papillomas, suggesting 
that our samples suffered significant fragmentation of the 
DNA. Alternatively, the specimens may have contained 
analytes that significantly inhibited the enzymatic activi-
ty of the PCR reaction. These possibilities likely explain 
our low rate of HPV detection. Interestingly, however, 
the inability to detect β-globin did not preclude detection 
of HPV in our samples. Similar to our results, Park et al. 
identified HPV in both β–globin negative and β–globin 
positive samples (14). They postulated this could be due 
to a large quantity of HPV DNA present in the specimen 
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or greater accessibility of HPV DNA compared to β–
globin DNA. Other possible explanations could include 
pipetting error, differences in assay sensitivity or geno-
mic variability of human β-globin sequences in primer 
target regions.
The amount of cross-linking has been reported as pro-
portional to fixation time (8). Therefore, we examined 
the relationship between fixation time and the quality 
and quantity of DNA obtained from our specimens. We 
did not find any significant differences in DNA quality 
or quantity among our samples when accounting for len-
gth of time spent in formalin. Park et al. also found no 
decrease in β-globin amplification rate with specimens 
that had been stored for longer periods of time (14).  
Investigators have used various approaches to mitigate 
the problem of DNA fragmentation. Kocjan et al. re-
commend an additional 1-hour incubation step for fur-
ther removal of formalin crosslinks to improve amplifi-
cation of HPV DNA fragments longer than 250 bp (8). 
Considering PCR assay design, Steinau et al. suggest 
that 450bp may represent the size limit for amplifica-
tion of DNA from FFPE specimens (16). Amplification 
of shorter segments (<270 bp) of the HPV genome im-
proves PCR sensitivity and is preferred for FFPE tissues 
(8).  HPV detection rates have been shown to be signi-
ficantly higher when targeting shorter PCR amplicons 
compared to larger ones because the shorter segments 
are likely to remain intact and be successfully amplified 
(14,17). In this study, we amplified a 65bp segment of 
the HPV L1 gene using the published primer pair desig-
nated SPF1/2 (9); however, this assay did not improve 
our HPV detection rates compared to the standard 450bp 
MY09/11 PCR assay typically used to amplify mucosal 
HPV genotypes. 
Another possible explanation for the lack of detection 
of HPV in oral squamous papillomas is that the standard 
MY09/11 PCR assay was designed to target predomi-
nantly mucosal HPV genotypes commonly infecting the 
female genital tract. Studies have shown that oral spe-
cimens may contain HPV genotypes more commonly 
thought to infect the cutaneous epithelium (18-22). All 
three primers used in our study target a relatively con-
served region of the L1 gene, which encodes the HPV 
major capsid protein. While MY09/11 primers detect a 
relatively broad spectrum of mucosal HPV genotypes, 
the FAP59/64 primer set (480bp) captures a broader 
spectrum of HPV genotypes, including cutaneous ge-
notypes (10). Amplification with this primer set did not 
substantially improve our HPV detection rates over that 
of the MY09/11 PCR, consistent with the finding that 
our specimens contained HPV-6 or 11, the genotypes 
classically associated with oral squamous papilloma and 
genital warts.
The method of sample collection also appears to impact 
HPV detection, with much higher prevalence reported 
among exfoliated mucosal cells (by mouthwash or scra-
ping) compared to biopsy specimens (23). Again, this 
is likely due to the need for formalin fixation of tissue 
that leads to poor quality DNA in comparison to that ob-
tained from exfoliated cells. The reported prevalence of 
HPV DNA in normal oral mucosa ranges from 0-100% 
(23-25) but is estimated to be about 7% (26). Identifica-
tion of HPV DNA in some squamous papillomas could 
simply represent oral mucosal carriage.  However, HPV 
16 is the most common genotype identified in normal 
oral mucosa (23,26) whereas genotypes 6 and 11 are the 
ones which have been identified in oral papillomas.  
Conclusion
Oral squamous papillomas have been attributed to low-
risk HPV infections however viral DNA cannot be detec-
ted in a significant proportion of lesions. This contrasts 
with other papillary oral lesions such as condyloma acu-
minatum in which nearly all cases are HPV-positive. We 
consider the possibility that some papillomas may not 
be caused by HPV infection although there are multi-
ple alternative explanations. Oral HPV infection could 
be transient in nature and therefore no longer detectable 
a certain time after having induced a clinical lesion. It 
is unlikely that the specimens contained genotypes di-
fferent from the probes we used in our experiment. In 
agreement with previous reports, we detected no hi-
gh-risk HPV genotypes within our papilloma specimens. 
Technical challenges with DNA extraction from FFPE 
tissues are well known. Inadequate DNA extraction un-
derestimates the prevalence of HPV. We believe this oc-
curred in our study given the low percentage of β–globin 
positive samples. When we consider only the β–globin 
positive samples, 36% (6 of 17) contained HPV DNA; 
this may be a more accurate representation of true HPV 
prevalence in papillomas.  
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